Resources

Agreement aims to accelerate the discovery of new therapeutics SAN DIEGO, Calif. – September 14, 2021 – AlivaMab Discovery Services (“ADS”), a ...

Jonah Rainey, Ph.D., joins ADS to bring new breadth and depth of capabilities and expertise in discovering therapeutic antibody modalities ...

Expansion gives AlivaMab Discovery Services the ability to streamline the transition of drug discovery programs into development SAN DIEGO, Calif ...

This case study details AlivaMab Discovery Services delivering high affinity antibody drug candidates for a virtual client.

This case study shows AlivaMab Discovery Services breaking immune tolerance to create antibodies against conserved targets.

This case study demonstrates how AlivaMab Discovery Services can overcome challenges of membrane protein drug development.